Qube Research & Technologies Ltd - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 146 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$963,616
-32.6%
75,756
-25.4%
0.00%
-40.0%
Q2 2023$1,429,782
-46.9%
101,547
-38.2%
0.01%
-64.3%
Q4 2022$2,691,664
+19.7%
164,226
+35.1%
0.01%
+7.7%
Q3 2022$2,248,000
+147.9%
121,516
+76.1%
0.01%
+85.7%
Q2 2022$907,000
+174.8%
68,994
+1200.8%
0.01%
-30.0%
Q4 2019$330,0005,3040.01%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 4,104,140$93,041,00043.52%
SV Health Investors, LLC 1,716,303$38,909,00020.55%
PURA VIDA INVESTMENTS, LLC 68,154$1,545,0000.65%
Redmile Group, LLC 683,880$14,658,0000.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 77,000$1,746,0000.62%
SPHERA FUNDS MANAGEMENT LTD. 224,154$5,008,0000.59%
EMERALD ADVISERS, LLC 482,626$10,941,0000.42%
EMERALD MUTUAL FUND ADVISERS TRUST 416,342$9,438,0000.38%
Orbimed Advisors 1,176,070$26,662,0000.34%
VIKING GLOBAL INVESTORS LP 2,394,625$54,286,0000.33%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders